FIELD: medicine.
SUBSTANCE: method for determination of the risk of highly-malignant serous ovarian carcinoma development (HMSOC) based on changes in the cellular composition of fallopian tube epithelium includes application of an equation with inclusion of a number of secretory cells proliferation sites (SCP), secretory cells spread (SCS) and patients age (AGE, at least 47 years): HMSOC=0.22*SCP+0.055*SCS-0.068*AGE+0.72, when the function value is above 1.663, the patient refers to a high-risk group for HMSOC, when the value is less than 1.663 - to a low-risk group.
EFFECT: early diagnosis of serous ovarian carcinomas of high degree of malignancy.
6 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR EARLY DIAGNOSIS OF NEOPLASTIC TRANSFORMATION OF ENDOMETRIOID OVARIAN CYSTS | 2020 | 
 | RU2730952C1 | 
| METHOD FOR PREDICTING RECURRENCE OF SEROUS OVARIAN CARCINOMA | 2020 | 
 | RU2749361C1 | 
| METHOD FOR PREDICTING PRE-CANCER DISEASES OF UTERINE CERVIX IN WOMEN WITH PAPILLOMA-VIRAL INFECTION | 2006 | 
 | RU2310197C1 | 
| METHOD FOR USING IMMUNOLOGICAL MARKERS FOR PREDICTION OF PROLIFERATIONS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH PAPILLOMAVIRUS INFECTION | 2012 | 
 | RU2520746C1 | 
| METHOD FOR PREDICTING THE RECURRENCE OF ENDOMETRIAL CYSTS AFTER SURGICAL TREATMENT BY MEANS OF IMMUNOHISTOCHEMICAL MARKERS | 2017 | 
 | RU2681219C1 | 
| METHOD OF PREDICTING PROGRESSION OF MILD INTRAEPITHELIAL NEOPLASIA IN WOMEN OF YOUNG AND FIRST PERIOD OF MATURE AGE | 2014 | 
 | RU2572340C1 | 
| METHOD FOR EARLY DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS (CIN) BASED ON METABOLIC MARKERS STUDY | 2016 | 
 | RU2629632C1 | 
| METHOD OF DETERMINING DURATION OF RECURRENCE-FREE INTERVAL IN SEROUS OVARIAN CANCER | 2015 |  | RU2613302C1 | 
| METHOD OF PREDICTING RISK OF EARLY RECURRENCE OF ENDOMETRIAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH STAGE I OF DISEASE | 2023 | 
 | RU2812609C1 | 
| METHOD FOR ASSESSING THE RISK OF PROGRESSION OF INTRAEPITHELIAL CERVICAL NEOPLASIA AND DEVELOPMENT OF CERVICAL CANCER BY DETERMINING THE LEVELS OF HUMAN MRNA GENES | 2015 | 
 | RU2660360C2 | 
Authors
Dates
2018-01-15—Published
2016-12-22—Filed